Interventions to increase attendance for diabetic retinopathy screening

Cochrane Database of Systematic Reviews

Volumn 2016, Issue 1, 2016, Pages

  Lawrenson, John G ^a   Graham Rowe, Ella ^a   Lorencatto, Fabiana ^a   Presseau, Justin ^b   Burr, Jennifer ^c   Ivers, Noah ^d   Quartilho, Ana ^e   Bunce, Catey ^e   Francis, Jillian J ^a   Grimshaw, Jeremy M ^b,f   Peto, Tunde ^e   Rice, Stephen ^g   Vale, Luke ^g  

^a CITY UNIVERSITY   (United Kingdom)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF ST ANDREWS   (United Kingdom)

^d WOMEN S COLLEGE HOSPITAL   (Canada)

^e MOORFIELDS EYE HOSPITAL   (United Kingdom)

^f UNIVERSITY OF OTTAWA   (Canada)

^g NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BEHAVIOR CHANGE; COST EFFECTIVENESS ANALYSIS; DIABETIC PATIENT; DIABETIC RETINOPATHY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTERVENTION STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW;

EID: 84969492171     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD012054     Document Type: Article

References (43)

1. American Diabetes Association. Standards of medical care in diabetes-2015 abridged for primary care providers. Clinical Diabetes 2015;33(2):97-111.
2. Byun SH, Ma SH, Jun JK, Jung KW, Park B. Screening for diabetic retinopathy and nephropathy in patients with diabetes: a nationwide survey in Korea. PloS One 2013;8(5):e62991.
3. CCEMG - EPPI-Centre Cost Converter v1.4. eppi.ioe.ac.uk/costconversion/default.aspx (accessed 1 September 2015).
4. Drummond MF, Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. BMJ 1996;313(7052):275-83.
5. Anonymous . Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 1991;98(Suppl 5):786-806.
6. Cochrane Effective Practice and Organisation of Care Group. EPOC taxonomy of interventions. epoc.cochrane.org/sites/epoc.cochrane.org/files/uploads/datacollectionchecklist.pdf (accessed 3 November 2015).
7. Cochrane Effective Practice and Organisation of Care Group. Suggested risk of bias criteria for EPOC reviews. epoc.cochrane.org/sites/epoc.cochrane.org/files/uploads/Suggested%20risk%20of%20bias%20criteria%20for%20EPOC%20reviews.pdf (accessed 3 November 2015).
8. Evans JR, Michelessi M, Virgili G. Laser photocoagulation for proliferative diabetic retinopathy. Cochrane Database of Systematic Reviews 2014, Issue 11. [DOI: 10.1002/14651858.CD011234.pub2]
9. Everett T, Bryant A, Griffin MF, Martin-Hirsch PP, Forbes CA, Jepson RG. Interventions targeted at women to encourage the uptake of cervical screening. Cochrane Database of Systematic Reviews 2011, Issue 5. [DOI: 10.1002/14651858.CD002834.pub2]
10. Glanville JM, Lefebvre C, Miles JN, Camosso-Stefinovic J. How to identify randomized controlled trials in MEDLINE: ten years on. Journal of the Medical Library Association 2006;94(2):1306.
11. Grimshaw JM, Thomas RE, MacLennan G, Fraser C, Ramsay CR, Vale L, et al. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technology Assessment 2004;8(6):iii-iv, 1-72.
12. Grimshaw JM, Presseau J, Tetroe J, Eccles MP, Francis JJ, Godin G, et al. Looking inside the black box: results of a theory-based process evaluation exploring the results of a randomized controlled trial of printed educational messages to increase primary care physicians' diabetic retinopathy referrals [Trial registration number ISRCTN72772651]. Implementation Science : IS 2014;9:86.
13. Gulliford MC, Dodhia H, Chamley M, McCormick K, Mohamed M, Naithani S, et al. Socio-economic and ethnic inequalities in diabetes retinal screening. Diabetic Medicine : a journal of the British Diabetic Association 2010;27(3):282-8.
14. Heintz E, Wirehn AB, Peebo BB, Rosenqvist U, Levin LA. Prevalence and healthcare costs of diabetic retinopathy: a population-based register study in Sweden. Diabetologia 2010;53(10):2147-54.
15. Higgins JPT, Deeks JJ, Altman DG (editors). Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
16. Holden DJ, Jonas DE, Porterfield DS, Reuland D, Harris R. Systematic review: enhancing the use and quality of colorectal cancer screening. Annals of Internal Medicine 2010;152(10):668-76.
17. Hutchinson A, McIntosh A, Peters J, O'Keeffe C, Khunti K, Baker R, et al. Effectiveness of screening and monitoring tests for diabetic retinopathy--a systematic review. Diabetic Medicine 2000;17(7):495-506.
18. Hwang J, Rudnisky C, Bowen S, Johnson JA. Socioeconomic factors associated with visual impairment and ophthalmic care utilization in patients with type II diabetes. Canadian Journal of Ophthalmology 2015;50(2):119-26.
19. Ivers N, Tricco AC, Trikalinos TA, Dahabreh IJ, Danko KJ, Moher D, et al. Seeing the forests and the trees-innovative approaches to exploring heterogeneity in systematic reviews of complex interventions to enhance health system decision-making: a protocol. Systematic Reviews 2014;3:88.
20. Jones S, Edwards RT. Diabetic retinopathy screening: a systematic review of the economic evidence. Diabetic Medicine 2010;27(3):249-56.
21. Kirkizlar E, Serban N, Sisson JA, Swann JL, Barnes CS, Williams MD. Evaluation of telemedicine for screening of diabetic retinopathy in the Veterans Health Administration. Ophthalmology 2013;120(12):2604-10.
22. Kliner M, Fell G, Gibbons C, Dhothar M, Mookhtiar M, Cassels-Brown A. Diabetic retinopathy equity profile in a multi-ethnic, deprived population in Northern England. Eye 2012;26(5):671-7.
23. Kristinsson JK, Gudmundsson JR, Stefansson E, Jonasson F, Gislason I, Thorsson AV. Screening for diabetic retinopathy. Initiation and frequency. Acta Ophthalmologica Scandinavica 1995;73(6):525-8.
24. Lorencatto F, West R, Stavri Z, Michie S. How well is intervention content described in published reports of smoking cessation interventions?. Nicotine & Tobacco Research 2013;15(7):1273-82.
25. Michie S, Fixsen D, Grimshaw JM, Eccles MP. Specifying and reporting complex behaviour change interventions: the need for a scientific method. Implementation Science 2009; Vol. 4:40.
26. Michie S, Richardson M, Johnston M, Abraham C, Francis J, Hardeman W, et al. The behavior change technique taxonomy (v1) of 93 hierarchically clustered techniques: building an international consensus for the reporting of behavior change interventions. Annals of Behavioral Medicine 2013;46(1):81-95.
27. Millett C, Dodhia H. Diabetes retinopathy screening: audit of equity in participation and selected outcomes in South East London. Journal of Medical Screening 2006;13(3):152-5.
28. O'Neill J, Tabish H, Welch V, Petticrew M, Pottie K, Clarke M, et al. Applying an equity lens to interventions: using PROGRESS ensures consideration of socially stratifying factors to illuminate inequities in health. Journal of Clinical Epidemiology 2014;67(1):56-64.
29. Paz SH, Varma R, Klein R, Wu J, Azen SP. Noncompliance with vision care guidelines in Latinos with type 2 diabetes mellitus: the Los Angeles Latino Eye Study. Ophthalmology 2006;113(8):1372-7.
30. Presseau J, Ivers NM, Newham JJ, Knittle K, Danko KJ, Grimshaw JM. Using a behaviour change techniques taxonomy to identify active ingredients within trials of implementation interventions for diabetes care. Implementation Science 2015;10:55.
31. Ramsey SD, Willke RJ, Glick H, Reed SD, Augustovski F, Jonsson B, et al. Cost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force report. Value in Health 2015;18(2):161-72.
32. The Nordic Cochrane Centre. The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre. The Cochrane Collaboration, 2014.
33. Saadine JB, Fong DS, Yao J. Factors associated with follow-up eye examinations among persons with diabetes. Retina 2008;28(2):195-200.
34. Scanlon PH. The English national screening programme for sight-threatening diabetic retinopathy. Journal of Medical Screening 2008;15(1):1-4.
35. Sharp PF, Olson J, Strachan F, Hipwell J, Ludbrook A, O'Donnell M, et al. The value of digital imaging in diabetic retinopathy. Health Technology Assessment 2003;7(30):1-119.
36. Silva PS, Cavallerano JD, Aiello LM. Ocular telehealth initiatives in diabetic retinopathy. Current Diabetes Reports 2009;9(4):265-71.
37. Sivaprasad S, Gupta B, Crosby-Nwaobi R, Evans J. Prevalence of diabetic retinopathy in various ethnic groups: a worldwide perspective. Survey of Ophthalmology 2012;57(4):347-70.
38. Taylor CR, Merin LM, Salunga AM, Hepworth JT, Crutcher TD, O'Day DM, et al. Improving diabetic retinopathy screening ratios using telemedicine-based digital retinal imaging technology: the Vine Hill study. Diabetes Care 2007;30(3):574-8.
39. Tricco AC, Ivers NM, Grimshaw JM, Moher D, Turner L, Galipeau J, et al. Effectiveness of quality improvement strategies on the management of diabetes: a systematic review and meta-analysis. Lancet 2012;379(9833):2252-61.
40. Virgili G, Parravano M, Menchini F, Evans JR. Anti-vascular endothelial growth factor for diabetic macular oedema. Cochrane Database of Systematic Reviews 2014, Issue 10. [DOI: 10.1002/14651858.CD007419.pub4]
41. Williams GA, Scott IU, Haller JA, Maguire AM, Marcus D, McDonald HR. Single-field fundus photography for diabetic retinopathy screening: a report by the American Academy of Ophthalmology. Ophthalmology 2004;111(5):1055-62.
42. Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012;35(3):556-64.
43. Zhang X, Norris SL, Saadine J, Chowdhury FM, Horsley T, Kanjilal S, et al. Effectiveness of interventions to promote screening for diabetic retinopathy. American Journal of Preventive Medicine 2007;33(4):318-35.